Gossamer Bio, Inc. (GOSS) Total liabilities 2022–2025
Gossamer Bio, Inc. (GOSS) total liabilities at each fiscal year-end, per SEC filings.
$295.0MFY2025 · since FY2022: $260.4M → $295.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $295.0M | +3.2% |
| FY2024 | $285.8M | +14.7% |
| FY2023 | $249.1M | -4.3% |
| FY2022 | $260.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice